Maxim Group downgraded Cancer Genetics, Inc. (NASDAQ: CGIX) from Buy to Hold.Analyst Jason McCarthy commented, "We are downgrading CGIX to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE